Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry Kenakin

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
Molecular Pharmacology|December 18, 2010
Histidine 6.55 is a major determinant of ligand-biased signaling in dopamine D2L receptorNuska Tschammer, Stefan Bollinger, Terry Kenakin, et al.
Molecular Pharmacology|January 13, 2005
The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitorChristian Watson, Stephen Jenkinson, Wieslaw Kazmierski, et al.
Pharmacological Reviews|December 6, 2003
International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacologyRichard R Neubig, Michael Spedding, Terry Kenakin, et al.
Advances in Pharmacology (San Diego, Calif.)|May 18, 2020
The function and allosteric control of the human sweet taste receptorGuy Servant, Terry Kenakin, Lan Zhang, et al.
Current Drug Targets. Infectious Disorders|December 5, 2002
CCR5 chemokine receptors: gatekeepers of HIV-1 infectionWieslaw M Kazmierski, Larry Boone, Wendell Lawrence, et al.
ACS Chemical Neuroscience|August 4, 2012
A simple method for quantifying functional selectivity and agonist biasTerry Kenakin, Christian Watson, Vanessa Muniz-Medina, et al.
Molecular Pharmacology|June 30, 2018
Equilibrium Assays Are Required to Accurately Characterize the Activity Profiles of Drugs Modulating Gq-Protein-Coupled ReceptorsSara Bdioui, Julien Verdi, Nicolas Pierre, et al.
Current Protocols in Pharmacology|September 29, 2011
Functional screening in the melanophore bioassayChanna Jayawickreme, Howard Sauls, Chris Watson, et al.
Journal of Receptor and Signal Transduction Research|July 20, 2019
The pharmacologic characterization of allosteric molecules: Gq protein activationSara Bdioui, Julien Verdi, Nicolas Pierre, et al.
Bioorganic & Medicinal Chemistry|June 6, 2003
Recent progress in discovery of small-molecule CCR5 chemokine receptor ligands as HIV-1 inhibitorsWieslaw Kazmierski, Neil Bifulco, Hanbiao Yang, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Molecular Pharmacology|December 18, 2010
Histidine 6.55 is a major determinant of ligand-biased signaling in dopamine D2L receptorNuska Tschammer, Stefan Bollinger, Terry Kenakin, et al.
Molecular Pharmacology|January 13, 2005
The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitorChristian Watson, Stephen Jenkinson, Wieslaw Kazmierski, et al.
Pharmacological Reviews|December 6, 2003
International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacologyRichard R Neubig, Michael Spedding, Terry Kenakin, et al.
Advances in Pharmacology (San Diego, Calif.)|May 18, 2020
The function and allosteric control of the human sweet taste receptorGuy Servant, Terry Kenakin, Lan Zhang, et al.
Current Drug Targets. Infectious Disorders|December 5, 2002
CCR5 chemokine receptors: gatekeepers of HIV-1 infectionWieslaw M Kazmierski, Larry Boone, Wendell Lawrence, et al.
ACS Chemical Neuroscience|August 4, 2012
A simple method for quantifying functional selectivity and agonist biasTerry Kenakin, Christian Watson, Vanessa Muniz-Medina, et al.
Molecular Pharmacology|June 30, 2018
Equilibrium Assays Are Required to Accurately Characterize the Activity Profiles of Drugs Modulating Gq-Protein-Coupled ReceptorsSara Bdioui, Julien Verdi, Nicolas Pierre, et al.
Current Protocols in Pharmacology|September 29, 2011
Functional screening in the melanophore bioassayChanna Jayawickreme, Howard Sauls, Chris Watson, et al.
Journal of Receptor and Signal Transduction Research|July 20, 2019
The pharmacologic characterization of allosteric molecules: Gq protein activationSara Bdioui, Julien Verdi, Nicolas Pierre, et al.
Bioorganic & Medicinal Chemistry|June 6, 2003
Recent progress in discovery of small-molecule CCR5 chemokine receptor ligands as HIV-1 inhibitorsWieslaw Kazmierski, Neil Bifulco, Hanbiao Yang, et al.
Pageof 12